ISSN: 1300 - 6525 E-ISSN: 2149 - 0880
kulak burun boÄŸaz
ve baÅŸ boyun cerrahisi dergisi
http://dergi.kbb-bbc.org.tr
Kayıtlı İndeksler








ORIGINAL RESEARCH

Determination of the Voice Parameters in Patients with Ankylosing Spondylitis
Ankilozan Spondilitli Hastalarda Ses Parametrelerinin Belirlenmesi
Received Date : 13 Nov 2020
Accepted Date : 10 Feb 2021
Available Online : 23 Mar 2021
Doi: 10.24179/kbbbbc.2020-79991 - Makale Dili: EN
KBB ve BBC Dergisi. 2021;29(2):113-8
Copyright © 2020 by Turkey Association of Society of Ear Nose Throat and Head Neck Surgery. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Objective: To determine voice parameters in patients with ankylosing spondylitis (AS) by objective and subjective methods and to compare them with the healthy group. Material and Methods: Forty two (21 AS and 21 healthy volunteers, aged 18-65 years old) were included in the study. Participants were evaluated using the Voice Handicap Index-10 (VHI-10) to assess voice complaints. Laryngeal findings of participants with AS were performed by videolaryngoscopy. Maximum phonation time measurements and acoustic voice analysis Praat softwar (version 6.0.36, University of Amsterdam, The Netherlands) were performed to evaluate the presence of objective dysphonia. Results: According to the cut-off score of VHI-10, 19% of the participants in the study group had voice complaints. The prevalence of laryngeal symptoms of participants with AS was %38.1, but there was no cricoarytenoid joint involvement. Fundamental frequency and perturbation parameters of participants in study group were not statistically significant. Conclusion: In present study subjective voice complaints rate of individuals with AS were found to be higher than individuals without AS. There was no significant difference of objective values of the between groups
ÖZET
Amaç: Ankilozan spondilitli (AS) erişkin hastalarda, ses parametrelerini objektif ve subjektif yöntemlerle belirlemek ve sağlıklı grup ile karşılaştırmaktır. Gereç ve Yöntemler: Çalışmaya, 42 (21 AS, 21 sağlıklı gönüllü, 18-65 yaş arası) katılımcı dâhil edildi. Katılımcıların, subjektif ses şikâyetini değerlendirmek amacıyla Ses Handikap Endeksi- 10 (SHE-10) kullanıldı. AS’li katılımcıların laringeal bulguları videolaringoskopi kullanılarak belirlendi. Objektif disfoni varlığını değerlendirmek amacıyla maksimum fonasyon süresi ve akustik ses analizi (Praat yazılımı) değerleri kullanıldı. Bulgular: SHE-10’un kesme puanına göre çalışma grubundaki katılımcıların %19’unda subjektif ses şikâyeti belirlendi. AS’li katılımcıların %38,1’inde çeşitli laringeal semptomlar belirlendi, ancak krikoaritenoid eklem tutulumu yoktu. Çalışma grubundaki katılımcıların temel frekans ve pertürbasyon parametreleri istatistiksel olarak anlamlı değildi. Sonuç: Çalışmamızda, AS’li katılımcıların subjektif ses şikâyeti oranı daha yüksek olmasına rağmen objektif değerlendirmelerde fark bulunamamıştır. Çalışma, AS ile disfoni arasında ilişki olabileceğini göstermiş olsa da daha geniş katılımlı çalışmalara ihtiyaç duyulmaktadır.
KAYNAKLAR
  1. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;21;369(9570):1379-90. [Crossref] [PubMed] 
  2. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22(6):554-60. [Crossref] [PubMed] 
  3. Sari Ä°, Öztürk MA, Akkoç N. Treatment of ankylosing spondylitis. Turk J Med Sci. 2015;45(2):416-30. [Crossref] [PubMed] 
  4. Çeliker R. Ankilozan spondilit: klinik özellikleri. Romatizma. 2000;15(1):15-21. [Link] 
  5. Raychaudhuri SP, Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun. 2014;48-49:128-33. [Crossref] [PubMed] 
  6. Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, Aghaei H, Pakdel FD, Fatahi Y, et al. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 2018;100:198-204. [Crossref] [PubMed] 
  7. Beirith SC, Ikino CM, Pereira IA. [Laryngeal involvement in rheumatoid arthritis]. Braz J Otorhinolaryngol. 2013;79(2):233-8. [Crossref] [PubMed] 
  8. Castro MA, Dedivitis RA, Pfuetzenreiter Júnior EG, Barros AP, Queija Ddos S. [Videolaryngostroboscopy and voice evaluation in patients with rheumatoid arthritis]. Braz J Otorhinolaryngol. 2012;78(5):121-7. [Crossref] [PubMed] 
  9. Roy N, Tanner K, Merrill RM, Wright C, Miller KL, Kendall KA. Descriptive epidemiology of voice disorders in rheumatoid arthritis: prevalence, risk factors, and quality of life burden. J Voice. 2016;30(1):74-87. [Crossref] [PubMed] 
  10. Desuter G, Duprez T, Huart C, Gardiner Q, Verbruggen G. The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis--an effective therapy. Laryngoscope. 2011;121(2):335-8. [Crossref] 
  11. Miller FR, Wanamaker JR, Hicks DM, Tucker HM. Cricoarytenoid arthritis and ankylosing spondylitis. Arch Otolaryngol Head Neck Surg. 1994;120(2):214-6. [Crossref] [PubMed] 
  12. Kiliç MA, Okur E, Yildirim I, Oğüt F, DenizoÄŸlu I, Kizilay A, et al. [Reliability and validity of the Turkish version of the Voice Handicap Index]. Kulak Burun Bogaz Ihtis Derg. 2008; 18(3): 139-47. [PubMed] 
  13. Behlau M, Madazio G, Moreti F, Oliveira G, de Moraes Alves dos Santos L, Paulinelli BR, et al. Efficiency and cutoff values of self-assessment instruments on the impact of a voice problem. Journal of Voice. 2016;30(4):506.e9-e18. [Crossref] [PubMed] 
  14. OÄŸuz H, Kiliç MA, Åžafak MA. Comparison of results in two acoustic analysis programs: Praat and MDVP. Turk J Med Sci. 2011;41(5):835-41. [Link] 
  15. Boone DR, McFarlane SC, Von Berg SL, Zraick RI. The Voice and Voice Therapy. 7th ed. Boston, MA: Pearson/Allyn & Bacon; 2005. [Link] 
  16. Sanz L, Sistiaga JA, Lara AJ, Cuende E, García-Alcántara F, Rivera T. The prevalence of dysphonia, its association with immunomediated diseases and correlation with biochemical markers. J Voice. 2012;26(2):148-53. [Crossref] [PubMed] 
  17. Kim M, Sadoughi B. The Voice of Autoimmunity: antisynthetase syndrome manifesting as vocal fold bamboo nodes. Ann Otol Rhinol Laryngol. 2018;127(2):128-30. [Crossref] [PubMed] 
  18. Liu ZW, Masterson LM, Srouji IA, Musonda P, Scott DG. Voice symptoms in patients with autoimmune disease: a cross-sectional epidemiological study. Otolaryngol Head Neck Surg. 2012;147(6):1108-13. [Crossref] [PubMed] 
  19. Vázquez de la Iglesia F, Fernández González S, Gómez Mde L. Reflujo faringolaríngeo: correlación entre los síntomas y los signos mediante cuestionarios de valoración clínica y fibroendoscópica. Es suficiente para realizar el diagnóstico? [Laryngopharyngeal reflux: correlation between symptoms and signs by means of clinical assessment questionnaires and fibroendoscopy. Is this sufficient for diagnosis?]. Acta Otorrinolaringol Esp. 2007;58(9):421-5. [Crossref] [PubMed] 
  20. Roy N, Merrill RM, Thibeault S, Parsa RA, Gray SD, Smith EM. Prevalence of voice disorders in teachers and the general population. J Speech Lang Hear Res. 2004;47(2):281-93. [Crossref] [PubMed] 
  21. Titze IR, Lemke J, Montequin D. Populations in the U.S. workforce who rely on voice as a primary tool of trade: a preliminary report. J Voice. 1997;11(3):254-9. [Crossref] [PubMed] 
  22. Sünter AV, YiÄŸit Ö, Alkan Z, Burnaz Ö. Acoustic voice analysis findings in ankylosing spondylitis. Istanbul Med J. 2019;20(3):231-3. [Crossref] 
  23. Ferrand CT. Harmonics-to-noise ratio: an index of vocal aging. J Voice. 2002;16(4):480-7. [Crossref] [PubMed]